Literature DB >> 17985544

Alternative techniques for peripheral nerve repair: conduits and end-to-side neurorrhaphy.

B Battiston1, P Tos, L G Conforti, S Geuna.   

Abstract

Nowadays new techniques may help the surgeon in difficult cases of nerve tissue loss: when a gap is produced in a mixed nerve, the use of conduits can be an alternative to nerve grafts, which still represent the "gold standard" for this kind of lesions. We have applied biologic conduits (muscle inside a vein) in more than 40 cases since 1993 with 85% of good functional results for both sensory and mixed nerves up to 5 cm. The advantages of this technique are: (1) all graft material is easily withdrawn in the lesion area and thus is not necessary to perform any new incision; (2) the possibility of reconstructing nerve gaps up to 5 cm avoids secondary damage created by the withdrawal of healthy nerves; (3) the possibility for spontaneous orientation of regenerating nerve fibers is offered as fibers are allowed to search for their final target (chemiotropism). Furthermore, when the tissue loss is important or the proximal nerve stump is not available, so jeopardizing the possibility of recovery with traditional reconstruction, the use of end-to-side neurorrhaphy has been described to solve the problem. However the use of end-to-side neurorrhaphy in the clinical setting for motor recovery remains controversial. In our experience we had satisfying results only in 20% of cases and thus motor reconstruction in the absence of an available proximal nerve may be best handled by nerve to nerve transfers. By contrast we had good results in sensory nerve reconstruction (especially digital nerves) by end-to-side coaptation.

Mesh:

Year:  2007        PMID: 17985544     DOI: 10.1007/978-3-211-72958-8_10

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  7 in total

1.  Comparison of a distal end-to-side neurorrhaphy with a proximal-distal end-to-side neurorrhaphy: in a rat model.

Authors:  Mohammad Ali Hosseinian; Ali Gharibi Loron; Behzad Nemati; Mohsen Khandaghy
Journal:  Eur J Orthop Surg Traumatol       Date:  2015-09-07

2.  Electrophysiological and histopathological effects of mesenchymal stem cells in treatment of experimental rat model of sciatic nerve injury.

Authors:  Ercan Yarar; Enis Kuruoglu; Ersoy Kocabıcak; Adnan Altun; Eyup Genc; Hamit Ozyurek; Mehmet Kefeli; Abdullah Hilmi Marangoz; Keramettin Aydın; Cengiz Cokluk
Journal:  Int J Clin Exp Med       Date:  2015-06-15

3.  A systematic review and meta-analysis of studies comparing muscle-in-vein conduits with autologous nerve grafts for nerve reconstruction.

Authors:  Johannes C Heinzel; Mai Quyen Nguyen; Laura Kefalianakis; Cosima Prahm; Adrien Daigeler; David Hercher; Jonas Kolbenschlag
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

4.  Digital nerve injuries: a review of predictors of sensory recovery after microsurgical digital nerve repair.

Authors:  Joline F Mermans; Bas B G M Franssen; Jan Serroyen; Rene R W J Van der Hulst
Journal:  Hand (N Y)       Date:  2012-06-28

5.  Does crossover innervation really affect the clinical outcome? A comparison of outcome between unilateral and bilateral digital nerve repair.

Authors:  Melike Oruç; Kadri Ozer; Özlem Çolak; Yüksel Kankaya; Uğur Koçer
Journal:  Neural Regen Res       Date:  2016-09       Impact factor: 5.135

6.  Aligned fibers enhance nerve guide conduits when bridging peripheral nerve defects focused on early repair stage.

Authors:  Qi Quan; Hao-Ye Meng; Biao Chang; Guang-Bo Liu; Xiao-Qing Cheng; He Tang; Yu Wang; Jiang Peng; Qing Zhao; Shi-Bi Lu
Journal:  Neural Regen Res       Date:  2019-05       Impact factor: 5.135

7.  Immediate or Delayed Transplantation of a Vein Conduit Filled with Nasal Olfactory Stem Cells Improves Locomotion and Axogenesis in Rats after a Peroneal Nerve Loss of Substance.

Authors:  Maxime Bonnet; Gaëlle Guiraudie-Capraz; Tanguy Marqueste; Stéphane Garcia; Charlotte Jaloux; Patrick Decherchi; François Féron
Journal:  Int J Mol Sci       Date:  2020-04-11       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.